Celin Sabu
About Celin Sabu
Celin Sabu is a Senior Global Trial Manager in Cell Therapy at Bristol Myers Squibb, with extensive experience in clinical research and trial management across various organizations.
Current Role at Bristol Myers Squibb
Celin Sabu is currently serving as the Senior Global Trial Manager, Cell Therapy at Bristol Myers Squibb in New Jersey, United States. In this role, Celin is responsible for managing and overseeing global clinical trials related to cell therapy. This position involves coordinating with various stakeholders to ensure the successful execution of clinical trials and leveraging extensive experience in clinical research to drive the development of innovative cell therapy treatments.
Professional History
Celin Sabu's professional history includes various critical roles in prominent healthcare and pharmaceutical organizations. Prior to the current role at Bristol Myers Squibb, Celin worked at York University as a Course Developer for the Clinical Research Program from 2021 to 2022. Celin also served as the Clinical Operations Lead at Roche in Mississauga, Ontario, Canada, from 2017 to 2022. Earlier roles include Study Delivery Leader at AstraZeneca from 2014 to 2017, Clinical Research Coordinator at University Health Network – Princess Margaret Hospital from 2013 to 2014, and Senior Research Officer at Himalaya Bio Medical Inc. from 2012 to 2013.
Education and Expertise
Celin Sabu has a robust educational background in clinical research. Celin earned a Master of Science (MSc) in Clinical Research from Cranfield University, from 2006 to 2010. Additionally, Celin studied Cancer Genomics and Precision Medicine at Harvard Medical School. Demonstrating academic excellence, Celin graduated at the top of the class with a Bachelor of Science (BSc) from Mumbai University. The combination of rigorous academic training and extensive professional experience has equipped Celin with a deep understanding of clinical research methodologies and best practices.
Clinical Research Experience
Over the years, Celin Sabu has made significant contributions to the field of clinical research. Celin managed and coordinated over 60 clinical trials and 15 investigator-initiated studies. Key projects included leading trials funded by the Bill & Melinda Gates Foundation and the Indian Council of Medical Research, focusing on maternal health, childbirth, and early cancer detection. This extensive experience positions Celin as a skilled professional in planning and executing complex clinical trials, aiming to enhance public health outcomes.
Recognitions and Awards
Celin Sabu was recognized with the Scientific Affairs Excellence Award at AstraZeneca. This accolade was awarded for outstanding contributions in collaborating to deliver immuno-oncology studies and drive strategic research investments. Such recognition underscores Celin's expertise and dedication to advancing clinical research and therapeutic innovations.